Exploring the influence of the substituent at position 4 in a series of 3,4-dihydropyrimidin-2(1H)-one A2B adenosine receptor antagonists

被引：0

作者：

Abel Crespo

Abdelaziz El Maatougui

Jhonny Azuaje

Luz Escalante

María Majellaro

María Isabel Loza

José Brea

María Isabel Cadavid

Hugo Gutiérrez-de-Terán

Eddy Sotelo

机构：

[1] Universidade de Santiago de Compostela,Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS)

[2] Universidade de Santiago de Compostela,Departamento de Química Orgánica, Facultade de Farmacia

[3] Universidade de Santiago de Compostela,Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS)

[4] Uppsala University,Department of Cell and Molecular Biology, Uppsala Biomedicinska Centrum (BMC)

来源：

Chemistry of Heterocyclic Compounds | 2017年 / 53卷

关键词：

3,4-dihydropyrimidin-2(1; )-ones; adenosine antagonists; A2B adenosine receptor; A2B antagonists; structure–activity relationship;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

[graphic not available: see fulltext]

引用

页码：316 / 321

页数：5

共 94 条

[1] Fredholm BB(2000)undefined Naunyn-Schmiedeberg's Arch. Pharmacol. 362 299-undefined
[2] Arslan G(2004)undefined Biol. Chem. 1 34-undefined
[3] Halldner L(2011)undefined Pharmacol. Rev. 63 1-undefined
[4] Kull B(2006)undefined Curr. Pharm. Des. 12 2175-undefined
[5] Shulte G(2001)undefined Biochem. Pharmacol. 61 443-undefined
[6] Wasserman W(2008)undefined Chem. Rev. 108 238-undefined
[7] Lennarz WJ(2006)undefined Nat. Rev. Drug Discovery 5 247-undefined
[8] Lane MD(1992)undefined Biochem. Biophys. Res. Commun. 187 86-undefined
[9] Fredholm BB(2001)undefined Pharmacol. Rev. 53 527-undefined
[10] Ijzerman AP(2011)undefined Biochim. Biophys. Acta 1808 1329-undefined